Showing results (221-230 of 301) with videos related to
Sort By:
Pageof 31
Investigational New Drugs|January 1, 1985
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancerJ M Bennett, P Byrne, A Desai, et al.Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.Cytometry. Part B, Clinical Cytometry|April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypesE Paietta, O Goloubeva, D Neuberg, et al.American Journal of Hematology|April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneityE Paietta, D Neuberg, S Richards, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancerG Falkson, R S Gelman, R Dreicer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinomaJ M Bennett, H B Muss, J H Doroshow, et al.Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.Leukemia|August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)C Robles, K M Kim, M M Oken, et al.Critical Reviews in Oncology/Hematology|February 16, 2007
Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task forceSilvio Monfardini, M S Aapro, J M Bennett, et al.Pageof 31